GLP-1 Agonists Market worth $170.75 billion in 2033

ha aggiunto una foto Health

2026-08-05 09:25:05 -

The report "GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033 ", is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period....

0 Commenti 0 condivisioni 16 Views 0 Anteprima